Scheithauer, Werner <br/><br/>
Randomized multicenter phase II trial of oxaliplatin plus irinotecan versus raltitrexed as first-line treatment in advanced colorectal cancer.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jan 2002 
 - 165-72 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2002.20.1.165  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Antimetabolites, Antineoplastic--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Camptothecin--administration & dosage<br/>Colorectal Neoplasms--drug therapy<br/>Cross-Over Studies<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Drug Synergism<br/>Female<br/>Humans<br/>Irinotecan<br/>Male<br/>Middle Aged<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin<br/>Palliative Care<br/>Quinazolines--therapeutic use<br/>Survival Rate<br/>Thiophenes--therapeutic use